Modern taxonomy has delineated Streptococcus gallolyticus subsp. gallolyticus, S. gallolyticus subsp. pasteurianus, Streptococcus infantarius subsp. coli, and S. infantarius subsp. infantarius within the heterogenous group of previously designated clinical Streptococcus bovis bacteria. In the present study, 58 consecutive blood culture isolates initially designated S. bovis were further characterized by applying phenotypic and molecular genetic methods, and possible disease associations were investigated by studying the patients' records. Published phenotypic characteristics of S. gallolyticus and S. infantarius were not unequivocal and did not allow an unambiguous phenotypic differentiation of the 58 clinical isolates. However, full-length 16S rRNA gene sequences clearly assigned the strains to S. gallolyticus subsp. gallolyticus (n ‫؍‬ 29), S. gallolyticus subsp. pasteurianus (n ‫؍‬ 12), and S. infantarius subsp. coli (n ‫؍‬ 17). Only 28% of the patients with available records presented with endocarditis and 7% presented with colon carcinoma, whereas 37% of the patients had altered liver parenchyma and 28% had gall bladder disease as underlying diseases. Detailed antimicrobial susceptibility data on both S. gallolyticus subspecies and S. infantarius subsp. coli are given for the first time. As a result of the extensive characterization of the largest number of S. gallolyticus and S. infantarius human clinical isolates published so far, emended species descriptions are given. It is recommended that both clinical microbiologists and infectious disease specialists avoid the designation S. bovis for true S. gallolyticus and S. infantarius strains in the future in order to get a clearer picture of the possible disease associations of these species.
Since the late 1970s, clinical microbiologists and infectious disease specialists have had the engram of Streptococcus bovis endocarditis and the association of S. bovis and colon carcinoma whenever this taxon was isolated from human blood cultures (8) . Traditionally, S. bovis had been divided into the three biotypes I (mannitol fermentation positive), II/1 (mannitol negative and ␤-glucuronidase negative), and II/2 (mannitol negative and ␤-glucuronidase positive) (3, 13) . Since the mid-1980s, it was clear that S. bovis was a conglomerate of several genomospecies (4) . During the late 1990s and at the beginning of this decade, the group of Bouvet, Grimont, and Schlegel demonstrated that the former S. bovis biotype I belongs to Streptococcus gallolyticus subsp. gallolyticus (S. gallolyticus had been defined by Osawa et al. in 1995 [11] ), that the former biotype II/1 is, in fact, Streptococcus infantarius subsp. coli (intermittently designated Streptococcus lutetiensis by Poyart et al. [12] ), and that biotype II/2 is S. gallolyticus subsp. pasteurianus (intermittently designated S. pasteurianus [12] ) (14, 15) . However, the identity of previously designated S. bovis isolated from human blood cultures has, so far, not been systematically investigated in the light of modern taxonomy. Therefore, two large private clinical laboratories from southern Germany decided to elucidate the identity of S. bovis human blood culture strains consecutively isolated in their routine laboratories. The possible disease associations of taxonomically correctly identified strains also should be investigated. As a result of a comprehensive study applying both phenotypic and molecular genetic methods, emended species descriptions of S. gallolyticus and S. infantarius subsp. coli are given.
MATERIALS AND METHODS
Study subjects. Patients' records were available in 46 of 58 (79%) of the cases studied and were received from the medical institutions in which the patients were hospitalized.
Strains. T were received from the Culture Collection of the University of Göteborg (CCUG), Sweden. Strains with running numbers 1 to 34 and 55 to 58 (Table 1) were collected by Gärtner & Colleagues Laboratories, Ravensburg, Germany, and strains with running numbers 35 to 54 came from Limbach Laboratories, Heidelberg, Germany. Only one strain per patient was included in the present study. All 58 clinical strains were recovered from BACTEC blood culture bottles (BD, Heidelberg, Germany), which had been incubated for less than 3 days. Subcultures were grown on Columbia base sheep blood agar plates (SBA) (BD) after incubation for 20 to 24 h at 35°C in a 5% CO 2 -enriched atmosphere. Strains were stored in skim milk at Ϫ20°C until further use; the recovery of the strains was, again, on SBA.
Biochemical profiles and antigen detection. The commercial API 20 Strep and the Rapid ID 32 Strep identification systems (both from bioMérieux, Marcy lЈEtoile, France) were used according to the manufacturer's instructions, and reading was done by two independent researchers. Salt tolerance was examined in 6.5% NaCl nutrient broth (Heipha, Eppelheim, Germany) after incubating the tubes for 24 h at 35°C. The ability to grow (regardless of the esculin reaction) on bile esculin agar (BD) was tested by reading the plates after 48 h of incubation at 35°C. For the detection of the Lancefield group D antigen, a commercial antiserum was used (Oxoid, Basingstoke, United Kingdom).
Antimicrobial susceptibility testing. For the determination of MICs, all clinical strains included in the present study were tested by a microdilution method (cation-adjusted Mueller-Hinton broth with lysed horse blood) according to the published CLSI standard (1).
Molecular genetic investigations.
The analysis of the complete 16S rRNA gene sequences was performed according to a published protocol with broad-range primers TPU-1 (AGAGTTTGATCMTGGCTCAG) and RTU-8 (AAGGAGG TGATCCAKCCRCA) (5) . The following primers were used for cycle sequencing: TPU-1, TPU-2 (CCARACTCCTACGGGAGGCA), TPU-3 (CAGCMGC CGCGGTAATWC), TPU-4 (GGATTAGATACCCTGGTAGTCC), TPU-5 (A 
RESULTS
During a period of 23 months, Gärtner & Colleagues Laboratories collected 38 S. bovis isolates (Table 1) ; Limbach Laboratories collected 20 S. bovis strains during a 13-month period. The 58 isolates came from 33 different hospitals in which the patients were treated and which were located mainly in the southwestern part of Germany. Table 1 also gives the biographical data of all 58 patients included in the present study. Forty (69%) of the 58 patients were male, and 18 (31%) were female. The mean age of the male patients was 66.8 Ϯ 10.3 years and was similar for all three bacterial taxa groups detected; the mean age for the female patients was 72.7 Ϯ 10.7 years. Of all 228 blood culture bottles drawn from the 58 patients, 86% were positive for S. bovis. In 76% of the 58 cases, all blood cultures received from an individual patient became positive for S. bovis.
When applying 16S rRNA gene sequencing, 29 (50%) of all S. bovis strains finally were identified as S. gallolyticus subsp. gallolyticus, 12 strains (21%) as S. gallolyticus subsp. pasteurianus, and 17 strains (29%) as S. infantarius subsp. coli, whereas not a single strain of S. infantarius subsp. infantarius was detected. Table 2 outlines the most relevant clinical data of the patients. Interestingly, nearly two-thirds of the patients had a hepatobiliary disorder as the underlying disease. The following comorbidities were detected in the 46 patients with available patients' records: cardiovascular disease, 80%; diabetes mellitus, 35%; other malignancies, 22%; kidney disease, 15%; and respiratory disease, 13%. Endocarditis was present in less than one-third of all patients, and colon carcinoma was detected in less than 10% of all patients with S. bovis bacteremia. For 11 of the 46 patients, stool was screened for occult blood, but only 2 of 11 patients were positive. For 15 of the 46 patients colonoscopy was performed, but only two cases of colon carcinoma were detected. Six (13%) of the 46 patients died during the hospitalization in which S. bovis bacteremia occurred, but in only 2 of the 6 cases was S. bovis bacteremia the single cause leading to the patient's death. Particular biochemical reactions (Table 3) of S. gallolyticus and S. infantarius subsp. coli are not always clear-cut, i.e., either 0 or 100% positive. As given in Table 3 , reactions differed in the two different identification systems used due to different substrates or pH conditions in the commercial devices. Eight of the 29 (28%) S. gallolyticus subsp. gallolyticus strains, 5 of the 12 (42%) S. gallolyticus subsp. pasteurianus strains, and 2 of the 17 (12%) S. infantarius subsp. coli strains grew in 6.5% NaCl. All 29 S. gallolyticus subsp. gallolyticus strains grew on bile esculin agar, whereas 2 of the 12 (17%) S. gallolyticus subsp. pasteurianus strains and 11 of the 17 (65%) S. infantarius subsp. coli strains were unable to grow on bile esculin agar. Finally, 21 of the 29 (72%) S. gallolyticus subsp. gallolyticus strains reacted with Lancefield group D antiserum, but only 1 of the 12 (8%) S. gallolyticus subsp. pasteurianus strains and 10 of the 17 (59%) S. infantarius subsp. coli strains expressed the Lancefield group D antigen. Table 4 shows the antimicrobial susceptibility patterns of S. gallolyticus and S. infantarius subsp. coli. All 58 clinical isolates were susceptible to ␤-lactams and vancomycin. Variable susceptibility to erythromycin was detected mainly in S. gallolyticus, with MICs being either low (e.g., 0.06 g/ml) or high (e.g., Ͼ32 g/ml). For nearly all 58 clinical isolates, levofloxacin susceptibility fell into the intermediate susceptibility category. The majority of the isolates were resistant to tetracycline. There was a tendency of S. infantarius subsp. coli isolates to be a Number of patients for whom records were available. b Percentage of patients positive for the given feature out of those for whom records were available. more susceptible to antimicrobial agents than S. gallolyticus strains.
For comparative 16S rRNA gene analysis, we first sequenced the four type strains of S. gallolyticus (two subspecies) and S. infantarius (two subspecies). All 58 clinical isolates were compared to those derived from four type strain sequences, which have been deposited by us in GenBank as EU163500 (S. gallolyticus subsp. gallolyticus), EU163502 (S. gallolyticus subsp. pasteurianus), EU163503 (S. infantarius subsp. coli), and EU163504 (S. infantarius subsp. infantarius). The 16S rRNA gene sequences of the type strains available from the GenBank/EMBL database had been found to be unreliable, with, e.g., S. gallolyticus subsp. gallolyticus T (X94337), showing 34-bp differences (including 12 N residues) from the true sequence.
The 16S rRNA gene sequences of the strains belonging to a particular taxon were extremely highly conserved (Table 5) a Values are the percentages of strains positive for the indicated reaction. If two percentages per reaction are given, the upper number represents the data derived from using the Rapid ID 32 Strep identification system and the lower number the data from using the API 20 STREP identification system. (Table 5 ). In addition, S. gallolyticus subsp. gallolyticus has two other mismatches with S. infantarius subsp. coli (positions 182 and 238), and S. gallolyticus subsp. pasteurianus has another individual mismatch with S. infantarius subsp. coli at position 1419 (Table 5) .
DISCUSSION
To the best of our knowledge, the present study is the largest on consecutively isolated S. bovis blood culture isolates that applies appropriate nomenclature.
In our study, more male patients than females with S. bovis blood culture isolates were seen, as already reported in other studies (range, 66 to 82%) (2, 6, 18) . The mean age of the patients in our series was also similar to that of the other studies (range, 59 to 67 years) (2, 6, 18) . In contrast to most other studies on S. bovis blood culture isolates, we observed significantly fewer cases of endocarditis (29%) and colon carcinomas (7%) in all patients, whereas in the classic study by Ruoff et al., 94% of all bacteremic patients with S. bovis biotype I had endocarditis and 71% had colon carcinoma (13) . A more recent study found that S. bovis bacteremia in 62 of 64 cases was clinically significant and S. bovis biotype I was associated with endocarditis or colon carcinoma in 74 or 57% of all cases, respectively (2) . In the present study, colonoscopy was performed on 15 of 46 patients only. It is therefore not unlikely that some colon carcinomas have been missed. The reason for the overall lower percentage of endocarditis and colon carcinoma in our series is unclear but may indicate, at least in some geographic regions and at certain periods of time, that the association of S. bovis bacteremia and endocarditis and/or colon carcinoma is not as strong as previously thought. However, the association of S. bovis blood culture isolates and colon carcinoma in 7% of our present cases is still much higher than that for any other microorganism except for Clostridium septicum, which is associated with colon carcinoma in one-third of all cases with blood cultures positive for this particular bacterium (9) .
Interestingly, we observed that more than 60% of our patients had a hepatobiliary disorder as the underlying disease. Corredoira et al. (2) reported that 50% of their S. bovis bacteremia patients had liver or gall bladder disease, but this was seen mainly in S. bovis biotype II patients (i.e., either S. gallolyticus subsp. pasteurianus or S. infantarius subsp. coli), whereas we also found these underlying diseases in patients with S. gallolyticus subsp. gallolyticus.
We did not detect a single strain of S. infantarius subsp. infantarius in our series, whereas Schlegel et al. (15) reported on some clinical isolates. However, Schlegel et al. (15) also included a strain from dairy products and one from frozen vegetables, indicating that this subspecies also can be isolated from food products or, even more often, from these products than from bacteremia cases of humans.
The clinical microbiologist often is confronted with a differential diagnosis between S. bovis isolates and enterococci when greyish, catalase-negative, gram-positive cocci are isolated from blood cultures. In our experience, S. bovis usually exhibits smaller colonies than enterococci. It is important that, in our series, 15 of 58 (26%) S. bovis strains grew in 6.5% NaCl broth, which is in contrast to a statement in a reference text book (16) , so that this characteristic does not allow an unambiguous differentiation between enterococci (consistently salt tolerant) and S. bovis. Interestingly, we observed that all S. gallolyticus subsp. gallolyticus strains grew on bile esculin agar but that some S. gallolyticus subsp. pasteurianus strains and the majority of S. infantarius subsp. coli strains were unable to grow on this medium, which is, again, in contrast to the information provided in a major textbook (16). Schlegel et al. (14, 15) stated that their S. bovis isolates variably (e.g., 44% in S. infantarius subsp. coli) expressed the Lancefield group D antigen, and in our series 55% of all 58 S. bovis strains were positive for this reaction. Of note is that significantly fewer S. gallolyticus subsp. pasteurianus strains were expressing the Lancefield group D antigen than S. gallolyticus subsp. gallolyticus strains. Therefore, studies (2, 6) including only Lancefield group D streptococci isolated from blood cultures may have a bias toward S. gallolyticus subsp. gallolyticus and underestimate the number of S. gallolyticus subsp. pasteurianus strains. In summary, the traditional tests for enterococci (salt tolerance, growth on bile esculin agar, and expression of Lancefield group D antigen) do not allow a clear-cut distinction between enterococci and S. Streptococcus infantarius subsp. coli (in.fan.ta'ri.us. L. adj. infantarius relating to infants, the source of the type strain; co'li. Gr. n. colon, colon; gen. n. coli, of colon).
The cells are gram-positive cocci that occur in pairs or short chains and are nonmotile, nonsporulating, and catalase negative. Colonies on blood agar are circular, 1 mm in diameter after 24 h incubation at 37°C, unpigmented, and alpha-hemolytic. Growth is enhanced in a 5% CO 2 atmosphere. Strains show homogeneous growth in buffer dextrose and in brainheart infusion broths. Growth also occurs in MRS broth, without gas production. No exopolysaccharide production on 5% sucrose medium is observed. Strains are positive for VogesProskauer, leucine aminopeptidase, and alanyl-phenylalanylproline arylamidase tests. Arginine dihydrolase, alkaline phosphatase, and pyrrolidonyl-arylamidase tests are negative. Urea and hippurate are not hydrolyzed. Esculin hydrolysis is variable. Nearly all strains are ␣-galactosidase positive. They are negative for N-acetyl-␤-glucosaminidase, ␤-galactosidase, ␤-glucuronidase, glycyl-tryptophan arylamidase, and ␤-mannosidase. All strains produce acid from lactose, maltose, sucrose, and starch. They do not produce acid from arabinose, arabitol, cyclodextrine, inulin, D-mannitol, melezitose, ribose, sorbitol, and D-tagatose. Variable results occur with glycogen, trehalose, melibiose, methyl-h-D-glucopyranoside, pullulan, and D-raffinose. The type strain for this subspecies is HDP 90246 T (ϭ CCUG 47831 T ϭ NCDO 964 T ). The 16S rRNA gene sequence of the type strain has been deposited in GenBank under accession number EU163503.
